We are live on ! Find out more
BG

Bellevue Group Portfolio holdings

AUM $4.2B
1-Year Est. Return 54.85%
This Fund
S&P 500
This Quarter Est. Return
+3.94%
1 Year Est. Return
+54.85%
3 Year Est. Return
+140.3%
5 Year Est. Return
+171.01%
10 Year Est. Return
+915.55%
AUM
$9.45B
AUM Growth
+$719M
Cap. Flow
+$643M
Cap. Flow %
6.8%
Top 10 Hldgs %
29.09%
Holding
237
New
15
Increased
96
Reduced
78
Closed
21

Top Buys

Rank Stock Value
1
ACCD
Accolade Inc
ACCD
+$56.6M
2
RVMD icon
Revolution Medicines
RVMD
+$46M
3
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$43.7M
4
EPIX
ESSA Pharma
EPIX
+$42.4M
5
BDX icon
Becton Dickinson
BDX
+$33.4M

Top Sells

Rank Stock Value
1
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$86.9M
2
HALO icon
Halozyme
HALO
+$47.2M
3
GNMK
GenMark Diagnostics, Inc
GNMK
+$38.1M
4
ESPR
Esperion Therapeutics
ESPR
+$33.9M
5
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$33.3M

Sector Composition

Rank Sector Weight
1 Healthcare 95.93%
2 Industrials 0.88%
3 Technology 0.47%
4 Consumer Discretionary 0.04%
5 Financials 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DPZ icon
176
Domino's
DPZ
$11B
$368K ﹤0.01%
1,000
– –
DLB icon
177
Dolby
DLB
$4.72B
$355K ﹤0.01%
+3,600
New +$344K
SBUX icon
178
Starbucks
SBUX
$118B
$353K ﹤0.01%
3,234
-1,100
-25% -$115K
FAST icon
179
Fastenal
FAST
$54B
$352K ﹤0.01%
14,000
-6,000
-30% -$144K
IQV icon
180
IQVIA
IQV
$34.7B
$348K ﹤0.01%
1,800
-1,100
-38% -$207K
AZPN
181
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$346K ﹤0.01%
2,400
-600
-20% -$86.5K
INTU icon
182
Intuit
INTU
$81.1B
$345K ﹤0.01%
+900
New +$347K
A icon
183
Agilent Technologies
A
$39.1B
$343K ﹤0.01%
2,700
-20,700
-88% -$2.56M
MSCI icon
184
MSCI
MSCI
$40B
$342K ﹤0.01%
816
-370
-31% -$155K
ST icon
185
Sensata Technologies
ST
$6.65B
$342K ﹤0.01%
5,900
-4,000
-40% -$231K
TYL icon
186
Tyler Technologies
TYL
$12.2B
$340K ﹤0.01%
800
-300
-27% -$130K
ULTA icon
187
Ulta Beauty
ULTA
$20.4B
$340K ﹤0.01%
1,100
-900
-45% -$280K
WSO icon
188
Watsco Inc
WSO
$14.9B
$339K ﹤0.01%
1,300
-500
-28% -$123K
VRSN icon
189
VeriSign
VRSN
$25.3B
$338K ﹤0.01%
1,700
-400
-19% -$78.6K
ENTG icon
190
Entegris
ENTG
$19.7B
$335K ﹤0.01%
3,000
-2,300
-43% -$237K
ICE icon
191
Intercontinental Exchange
ICE
$82.4B
$335K ﹤0.01%
3,000
-1,800
-38% -$204K
STZ icon
192
Constellation Brands
STZ
$22.2B
$333K ﹤0.01%
1,459
-600
-29% -$135K
TRU icon
193
TransUnion
TRU
$14.8B
$333K ﹤0.01%
3,696
-1,400
-27% -$126K
SCI icon
194
Service Corp International
SCI
$11.4B
$332K ﹤0.01%
6,500
-2,000
-24% -$100K
WAB icon
195
Wabtec
WAB
$51.1B
$332K ﹤0.01%
4,200
-2,200
-34% -$171K
MKTX icon
196
MarketAxess Holdings
MKTX
$4.15B
$330K ﹤0.01%
662
-160
-19% -$85.3K
MTCH icon
197
Match Group
MTCH
$8.84B
$327K ﹤0.01%
2,378
-1,500
-39% -$225K
FDS icon
198
Factset
FDS
$9.05B
$324K ﹤0.01%
1,050
-250
-19% -$79.1K
OLED icon
199
Universal Display
OLED
$3.71B
$323K ﹤0.01%
+1,365
New +$315K
GGG icon
200
Graco
GGG
$12.9B
$322K ﹤0.01%
4,500
-2,100
-32% -$149K
6 7
8
9 10

Similar funds

WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $4.22B AUM 21.28% 1-Year Est. Return
HIP
HUB Investment Partners Austin, Texas $4.18B AUM 24.76% 1-Year Est. Return
DT
DV Trading Chicago, Illinois $4.22B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.23B AUM 20.9% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.17B AUM 28.5% 1-Year Est. Return
NCM
Nearwater Capital Markets Dublin 4, Dublin, Ireland $4.24B AUM 66.03% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

Bellevue Group's Q1 2021 Portfolio in Review

As of Q1 2021, Bellevue Group held 237 positions worth $9.45B, up 8.2% from $8.73B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Bellevue Group deployed $643M of net new capital in Q1 2021, opening 15 new positions and adding to 96 existing holdings. Its largest new stake was ESSA Pharma: 1,825,814 shares worth $53M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 96% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was GW Pharmaceuticals Plc American Depositary Shares, an estimated $86.9M trimmed.

  • Bellevue Group's largest Q1 2021 buy was ESSA Pharma: 1,825,814 shares worth $53M.
  • Bellevue Group added most to Accolade Inc in Q1 2021, an estimated $56.6M increase.
  • Bellevue Group's biggest Q1 2021 reduction was GW Pharmaceuticals Plc American Depositary Shares, cutting an estimated $86.9M.
  • Bellevue Group fully exited GenMark Diagnostics, Inc in Q1 2021, selling an estimated $38.1M.
  • Bellevue Group's ten largest holdings make up 29% of its $9.45B portfolio in Q1 2021.
  • Bellevue Group opened 15 new positions and closed 21 in Q1 2021.
  • Bellevue Group's portfolio value rose 8.2% quarter-over-quarter to $9.45B.

Based on Bellevue Group's 13F filing for Q1 2021, filed 12 May 2021.